Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

1,254

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Hypertension
Interventions
DRUG

Amlodipine

Amlodipine (5 mg and 10 mg) was provided as capsules taken orally once daily.

DRUG

hydrochlorothiazide

Hydrochlorothiazide 12.5 mg capsules were taken orally once daily

DRUG

Aliskiren

Aliskiren 150 mg and aliskiren 300 mg were provided as film-coated tablets, taken orally once daily.

Trial Locations (10)

Unknown

Investigative Site, Toronto

Investigative Site, San José

Investigative Site, Paris

Investigative Site, Bonn

Investigative Site, Athens

Investigative Site, Guatemala City

Investigative Site, Cape Town

Investigative Site, Basel

Investigative Site, London

Investigative Site, Caracas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00797862 - Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension | Biotech Hunter | Biotech Hunter